# Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders

> **NCT01571609** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 40 (actual)

## Conditions studied

- Hyperlipidemia
- Diabetes Mellitus
- Metabolic Syndrome
- Arterial Hypertension
- Obesity

## Interventions

- **OTHER:** first phase insulin secretion (FPIR), Hyperinsulinemic euglycemic clamp (HEC), glucose tracer, and palmitate tracer

## Key facts

- **NCT ID:** NCT01571609
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-07
- **Final completion:** 2014-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-12-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01571609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01571609, "Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01571609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*